| __timestamp | Incyte Corporation | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 165772000 | 59644696 |
| Thursday, January 1, 2015 | 196614000 | 79541000 |
| Friday, January 1, 2016 | 303251000 | 98015000 |
| Sunday, January 1, 2017 | 366406000 | 103958000 |
| Monday, January 1, 2018 | 434407000 | 103654000 |
| Tuesday, January 1, 2019 | 468711000 | 128951000 |
| Wednesday, January 1, 2020 | 516922000 | 135799000 |
| Friday, January 1, 2021 | 739560000 | 149883000 |
| Saturday, January 1, 2022 | 1002140000 | 220206000 |
| Sunday, January 1, 2023 | 1161300000 | 265542000 |
| Monday, January 1, 2024 | 1242157000 |
Data in motion
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Incyte Corporation and Travere Therapeutics, Inc. have taken different paths in this regard over the past decade. From 2014 to 2023, Incyte's SG&A expenses surged by approximately 600%, reflecting its aggressive expansion strategy. In contrast, Travere's expenses grew by around 345%, indicating a more conservative approach.
Incyte's expenses peaked in 2023, reaching nearly 1.16 billion, while Travere's were significantly lower at 266 million. This disparity highlights Incyte's larger scale and broader market reach. However, Travere's steadier growth suggests a focus on sustainable operations. As investors and analysts evaluate these companies, understanding their SG&A strategies provides valuable insights into their operational priorities and market positioning.
AbbVie Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? AstraZeneca PLC or Incyte Corporation
GSK plc or Incyte Corporation: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Incyte Corporation vs Insmed Incorporated
Breaking Down SG&A Expenses: Incyte Corporation vs Walgreens Boots Alliance, Inc.
Selling, General, and Administrative Costs: Incyte Corporation vs Verona Pharma plc
Incyte Corporation and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Jazz Pharmaceuticals plc and Travere Therapeutics, Inc.
Comparing SG&A Expenses: Grifols, S.A. vs Travere Therapeutics, Inc. Trends and Insights
Rhythm Pharmaceuticals, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Dynavax Technologies Corporation and Travere Therapeutics, Inc.
Taro Pharmaceutical Industries Ltd. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?